Giulia Mingrone

5PUBLICATIONS
10CO-AUTHORS
Haematological tumoursCardiology (incl. cardiovascular diseases)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 06, 2024
Correction: Colomba et al. Haemodynamic Forces: Emerging Markers of Ventricular Remodelling in Multiple Myeloma Cardiovascular Baseline Risk Assessment. Cancers 2024, 16, 3081.

Anna Colomba, Anna Astarita, Giulia Mingrone

|Sep 14, 2024
Haemodynamic Forces: Emerging Markers of Ventricular Remodelling in Multiple Myeloma Cardiovascular Baseline Risk Assessment.

Anna Colomba, Anna Astarita, Giulia Mingrone

|Feb 25, 2023
Patients with Very High Risk of Cardiovascular Adverse Events during Carfilzomib Therapy: Prevention and Management of Events in a Single Center Experience.

Giulia Mingrone, Anna Astarita, Anna Colomba

|Feb 11, 2023
Carfilzomib-Based Regimen and Cardiotoxicity in Multiple Myeloma: Incidence of Cardiovascular Events and Organ Damage in Carfilzomib-Dexamethasone versus Carfilzomib-Lenalidomide-Dexamethasone. A Real-Life Prospective Study.

Anna Astarita, Giulia Mingrone, Lorenzo Airale

|Apr 30, 2021
Multiple Myeloma Patients Undergoing Carfilzomib: Development and Validation of a Risk Score for Cardiovascular Adverse Events Prediction.

Anna Astarita, Giulia Mingrone, Lorenzo Airale

Pageof 1

Frequent Collaborators

5 joint publications

Alberto Milan

4 joint publications

Lorenzo Airale

4 joint publications

Francesca Gay

3 joint publications

Dario Leone